Skip Navigation

Cardiovascular Research 2004 64(3):457-466; doi:10.1016/j.cardiores.2004.07.022
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Caballero, R.
Right arrow Articles by Delpón, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caballero, R.
Right arrow Articles by Delpón, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations

Ricardo Caballero*,1, Ricardo Gómez1, Lucía Núñez, Ignacio Moreno, Juan Tamargo and Eva Delpón

Department of Pharmacology, School of Medicine, Universidad Complutense, 28040 Madrid, Spain

* Corresponding author. Tel.: +34 91 394 14 74; fax: +34 91 394 14 70. Email address: rcaballero{at}ift.csic.es

Objective: In the present study we examined the effects of diltiazem, an L-type Ca2+ channel blocker widely used for the control of the ventricular rate in patients with supraventricular arrhythmias, on hKv1.5 and Kv4.3 channels that generate the cardiac ultrarapid delayed rectifier (IKur) and the 4-aminopyridine sensitive transient outward (Ito) K+ currents, respectively.

Methods: hKv1.5 and Kv4.3 channels were stably and transiently expressed in mouse fibroblast and Chinese hamster ovary cells, respectively. Currents were recorded using the whole-cell patch clamp.

Results: Diltiazem (0.01 nM-500 µM) blocked hKv1.5 channels, in a frequency-dependent manner exhibiting a biphasic dose-response curve (IC50=4.8±1.5 nM and 42.3±3.6 µM). Diltiazem delayed the initial phase of the tail current decline and shifted the midpoint of the activation (Vh=–16.5±2.1 mV vs –20.4±2.6 mV, P<0.001) and inactivation (Vh=–22.4±0.7 mV vs. –28.2±1.9 mV, P<0.001) curves to more negative potentials. The analysis of the development of the diltiazem-induced block yielded apparent association (k) and dissociation (P) rate constants of (1.6±0.2)x106 M–1s–1 and 46.8±4.8 s–1, respectively. Diltiazem (0.1 nM-100 µM) also blocked Kv4.3 channels in a frequency-dependent manner exhibiting a biphasic dose-response curve (IC50=62.6±11.1 nM and 109.9±12.8 µM). Diltiazem decreased the peak current and, at concentrations ≤0.1 µM, accelerated the inactivation time course. The apparent association and dissociation rate constants resulted (1.7±0.2)x106 M–1s–1 and 258.6±38.1 s–1, respectively. Diltiazem, 10 nM, shifted to more negative potentials the voltage-dependence of Kv4.3 channel inactivation (Vh=–33.1±2.3 mV vs –38.2±3.5 mV, n=6, Plt;0.05) the blockade increasing at potentials at which the amount of inactivated channels increased.

Conclusion: The results demonstrated for the first time that diltiazem, at therapeutic concentrations, decreased hKv1.5 and Kv4.3 currents by binding to the open and the inactivated state of the channels.


1 These authors contributed equally to this work.

Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.